100
Participants
Start Date
August 31, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
August 31, 2026
Patients who are candidates for CAR-T cell therapy for hematologic malignancy
This study will include patients who undergo CAR-T cell infusion at participating centers during the 18-month duration of the enrollment period. A total of 100 patients are expected to be enrolled, including 80 patients for the prospective part and 20 for the retrospective part.
RECRUITING
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER